JPRN-UMIN000053387尚未招募Unknown
A randomized, single-blind, placebo-controlled, crossover study on the suppressive effects of viscosity-adjusted enteral formula on blood glucose level - Suppressive effects of a test food on blood glucose level
Seishukai Clinic0 个研究点目标入组 20 人开始时间: 2024年1月25日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Subjects who meet both of the following criteria in the preliminary survey. i)Fasting blood glucose level is 126 mg/dL or more. ii)HbA1c value is 6.5 % or more. 2)Subjects who have been diagnosed with diabetes. 3)Subjects taking medications that may affect blood glucose levels. 4)Subjects who are under medical treatment of diseases in liver, kidneys, heart, lungs, digestive system, blood, endocrine and metabolic systems, or who have serious medical history of those diseases. 5)Subjects who exhibit allergic symptoms due to intake of milk or soybean-derived ingredients. 6)Subjects who donated/collected blood components or 200 mL or more of blood in the past 1 month, or who donated/collected 400 mL or more of blood on the past 4 months. 7)Subjects who plan to participate in other clinical trials during the trial period. 8)Others who are judged by the investigator to be inappropriate as participants in this test.
研究者
相似试验
进行中（未招募）
1 期
The effects of lacosamide, pregabalin and tapentadol on biomarkers of peripheral pain processingHealthy volunteers (intended indication: pain)MedDRA version: 20.0Level: PTClassification code 10033371Term: PainSystem Organ Class: 10018065 - General disorders and administration site conditionsEUCTR2019-000942-36-DKAarhus University60
进行中（未招募）
1 期
The effects of lacosamide, pregabalin and tapentadol on biomarkers of pain processingHealthy subjects (intended indication: pain)MedDRA version: 20.0Level: PTClassification code 10033371Term: PainSystem Organ Class: 10018065 - General disorders and administration site conditionsEUCTR2019-001204-37-BEInstitute of Neuroscience (IoNS), Université catholique de Louvain56
进行中（未招募）
1 期
The effects of lacosamide, pregabalin and tapentadol on biomarkers of pain processingHealthy volunteers (intended indication: pain)MedDRA version: 20.0Level: PTClassification code 10033371Term: PainSystem Organ Class: 10018065 - General disorders and administration site conditionsEUCTR2019-000755-14-BESapienza University of Rome, Department of Human Neurosciences56
进行中（未招募）
1 期
Multi-center trial in healthy subjects to investigate the effects of analgesic drugs on pain processing observed by electroencephalography (EEG)Healthy volunteers (intended indication: pain)MedDRA version: 20.0Level: PTClassification code 10033371Term: PainSystem Organ Class: 10018065 - General disorders and administration site conditionsEUCTR2019-001204-37-ITMBERTO I - POLICLINICO DI ROMA56
进行中（未招募）
1 期
The effects of lacosamide, pregabalin and tapentadol on biomarkers of peripheral pain processingHealthy volunteers (intended indication: pain)MedDRA version: 20.0Level: PTClassification code 10033371Term: PainSystem Organ Class: 10018065 - General disorders and administration site conditionsEUCTR2019-000942-36-BEAarhus University60